Keating Financial Advisory Services’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Keating Financial Advisory Services's IDXX Position: Q2 2026 in Review
Keating Financial Advisory Services reduced its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, selling an estimated $33.1K and leaving 308 shares worth $162K. The position accounts for 0.02% of the portfolio, ranked #391.
Keating Financial Advisory Services first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $254K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Keating Financial Advisory Services held 308 shares of Idexx Laboratories worth $162K as of Q2 2026.
- Keating Financial Advisory Services sold 59 Idexx Laboratories shares in Q2 2026, an estimated $33.1K.
- Idexx Laboratories made up 0.02% of Keating Financial Advisory Services's portfolio in Q2 2026, its #391 holding.
- Keating Financial Advisory Services first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
- Keating Financial Advisory Services's Idexx Laboratories position peaked at $254K in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.